3, 5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof
Details for Australian Patent Application No. 2005316397 (hide)
International Classifications
Event Publications
5 July 2007 PCT application entered the National Phase
PCT publication WO2006/066080 Priority application(s): WO2006/066080
2 February 2012 Application Accepted
Published as AU-B-2005316397
31 May 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005316403-Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser